Ultra‐Rapid Lispro results in accelerated insulin lispro absorption and faster early insulin action in comparison with Humalog(®) in Japanese patients with type 1 diabetes

AIMS/INTRODUCTION: Ultra‐rapid lispro (URLi) is a novel ultra‐rapid mealtime insulin. This study compared the pharmacokinetic and glucodynamic profiles, safety, and tolerability of URLi and lispro (Humalog(®)) in Japanese patients with type 1 diabetes mellitus. MATERIALS AND METHODS: This was a phas...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Diabetes Investig
Hlavní autoři: Shiramoto, Masanari, Nasu, Risa, Oura, Tomonori, Imori, Makoto, Ohwaki, Kenji
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7232298/
https://ncbi.nlm.nih.gov/pubmed/31816193
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.13195
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky